Loading clinical trials...
Loading clinical trials...
The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnose...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Texas Southwestern Medical Center
NCT02014883 · Glut1 Deficiency Syndrome
NCT03202108 · Ketogenic Dieting, Epilepsy, and more
NCT03041363 · Epilepsy, GLUT1DS1, and more
NCT03722212 · Glut1 Deficiency Syndrome, De Vivo Disease, and more
NCT01993186 · Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
UT Southwestern Medical Center
Dallas, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions